Navellier & Associates Inc Repligen Corp Transaction History

Navellier & Associates Inc

$705 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$138.42 - $180.31 $43,463 - $56,617	314 Added 9.67%	3,562 $503,000
Q1 2023 May 12, 2023	BUY	$154.26 - $198.1 $18,819 - $24,168	122 Added 3.9%	3,248 $546,000
Q4 2022 Feb 02, 2023	SELL	$162.42 - $220.56 $12,668 - $17,203	-78 Reduced 2.43%	3,126 $529,000
Q3 2022 Nov 09, 2022	SELL	$160.42 - $256.21 $5,614 - $8,967	-35 Reduced 1.08%	3,204 $600,000
Q1 2022 Apr 29, 2022	SELL	$161.19 - $257.96 $81,239 - $130,011	-504 Reduced 13.47%	3,239 $609,000
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $8,665 - $10,656	-35 Reduced 0.93%	3,743 $991,000
Q3 2021 Oct 28, 2021	SELL	$194.77 - $324.21 $11,880 - $19,776	-61 Reduced 1.59%	3,778 $1.09 Million
Q2 2021 Aug 09, 2021	SELL	$165.87 - $220.95 $3.11 Million - $4.15 Million	-18,778 Reduced 83.03%	3,839 $766,000
Q1 2021 May 12, 2021	BUY	$180.37 - $226.26 $186,322 - $233,726	1,033 Added 4.79%	22,617 $4.4 Million
Q4 2020 Feb 05, 2021	BUY	$148.08 - $206.57 $2.7 Million - $3.76 Million	18,226 Added 542.76%	21,584 $4.14 Million
Q3 2020 Nov 09, 2020	SELL	$122.51 - $158.27 $170,411 - $220,153	-1,391 Reduced 29.29%	3,358 $495,000
Q2 2020 Aug 12, 2020	BUY	$94.33 - $140.48 $17,356 - $25,848	184 Added 4.03%	4,749 $587,000
Q1 2020 May 13, 2020	SELL	$84.96 - $109.14 $8,156 - $10,477	-96 Reduced 2.06%	4,565 $441,000
Q4 2019 Feb 12, 2020	SELL	$73.84 - $93.08 $696,089 - $877,465	-9,427 Reduced 66.92%	4,661 $431,000
Q3 2019 Oct 16, 2019	BUY	$76.65 - $95.51 $502,517 - $626,163	6,556 Added 87.04%	14,088 $1.08 Million
Q2 2019 Jul 17, 2019	BUY	$54.2 - $85.95 $408,234 - $647,375	7,532 New	7,532 $647,000

Others Institutions Holding RGEN

# of Institutions

485

Shares Held

54.1M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.26 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$1.06 Billion
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$837 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$269 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$236 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.

Account